Nemus Bioscience, Inc. (OTC: NMUS) is a biopharmaceutical company with a focus on the discovery, development and commercialization of therapeutics based on naturally-derived or synthetically manufactured cannabis compounds. The company develops therapeutic products to treat glaucoma and other optic nerve-related disorders and conditions associated with muscle spasticity, epilepsy, anxiety, and methicillin-resistant staphylococcus aureus. Founded in 2012, the company is based in Costa Mesa, California. For more information, visit the company’s website at www.nemusbioscience.com